Sio Gene Therapies Inc.
NASDAQ: SIOX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David W. Nassif
- Employees
- 12
- Headquarters
- New York City, United States
- IPO year
- 2015
- Website
- https://www.siogtx.com
Loading SIOX…
Loading profile data…Frequently asked questions about SIOX
What does Sio Gene Therapies Inc. (SIOX) do?
Sio Gene Therapies Inc. is a biotechnology company in the clinical development phase, committed to pioneering gene therapies designed to fundamentally alter the prognosis for patients afflicted with neurodegenerative conditions. Its therapeutic pipeline is supported by strategic licensing agreements, including one with Oxford BioMedica (UK) Ltd....
Where does SIOX trade?
Sio Gene Therapies Inc. (SIOX) trades on the NASDAQ Global Select.
What sector is SIOX in?
Sio Gene Therapies Inc. (SIOX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sio Gene Therapies Inc.?
David W. Nassif is the chief executive officer of Sio Gene Therapies Inc. (SIOX).
Where is Sio Gene Therapies Inc. headquartered?
Sio Gene Therapies Inc. is headquartered in United States.
Does SIOX pay a dividend?
Yes — Sio Gene Therapies Inc. (SIOX) paid a trailing twelve-month dividend of USD 0.43 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SIOX go public?
Sio Gene Therapies Inc. (SIOX) completed its initial public offering in 2015.